Comutations, follow-up, and outcomes after cessation of treatment. (A) Mutated genes at diagnosis and swimmer plot showing time of venetoclax treatment, response, and time off treatment. (B) OS and (C) molecular RFS in patients who ceased treatment after MRD negativity.